文献速递糖尿病

2型糖尿病既往低血糖的促血栓效应持续存在

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2018-10-16

结果显示低血糖在2型糖尿病中引起血小板反应性和聚集增加,且血凝块溶解时间和最大吸光度升高持续至第7天,纤维蛋白网密度增加,纤维蛋白原和补体C3也升高至第7天。结论提示既往低血糖具有急性且持久的促血栓效应,至少持续7天,在2型糖尿病患者中增强。

要点

  • 低血糖在2型糖尿病中引起急性血小板反应性增加,恢复后缓解。
  • 2型糖尿病低血糖后血凝块溶解时间和最大吸光度升高持续至第7天。
  • 低血糖后纤维蛋白原和补体C3在2型糖尿病中升高至第7天。

核心结论

  • 既往低血糖具有急性且持久的促血栓效应,至少持续7天,且在2型糖尿病患者中增强。
  • 这些机制可能解释低血糖增加短期和中期心血管死亡风险。

研究设计与样本

  • 配对高胰岛素-正常血糖钳夹(葡萄糖6 mmol/L,两个60分钟时段)与低血糖钳夹(葡萄糖2.5 mmol/L,两个60分钟时段),分日进行。
  • 在基线、钳夹结束及恢复后、第1天和第7天测量纤维蛋白凝块特性、血小板反应性和炎症标志物。

主要发现

  • 正常血糖高胰岛素血症在两组中均降低血小板反应性、降低纤维蛋白凝块密度并改善纤溶效率。
  • 低血糖期间两组血小板反应性和聚集增加,恢复时缓解。
  • 2型糖尿病中血凝块溶解时间和血凝块最大吸光度升高至第7天( vs 正常血糖 P=0.002 和 0.001)。
  • 无糖尿病对照组凝块变化有限。
  • 低血糖钳夹后第7天纤维蛋白网密度增加 Δ 1.15 ± 0.28 fibers/μm2(血糖臂 P<0.01)。

临床怎么用

  • 对2型糖尿病患者应重视低血糖事件后的血栓风险,尤其在有心血管风险者中。
  • 低血糖后至少7天内可能持续存在促血栓状态,需加强监测与管理。

局限性

  • 未报告心血管结局,仅为机制性替代终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hypoglycemia has been linked to persistent increases in cardiovascular (CV) mortality in type 2 diabetes after the event. Our aim was to examine acute and downstream effects of hypoglycemia on markers of thrombosis risk and inflammation in type 2 diabetes. RESEARCH DESIGN AND METHODS: Twelve individuals with type 2 diabetes with no history of CV disease and 11 age- and BMI-matched volunteers without diabetes underwent paired hyperinsulinemic-euglycemic (glucose 6 mmol/L for two 60-min periods) and hypoglycemic (glucose 2.5 mmol/L for two 60-min periods) clamps on separate occasions on day 0. Fibrin clot properties, platelet reactivity, and inflammatory markers were measured at baseline, end of and after recovery from the initial clamp, day 1, and day 7 using validated assays and electron microscopy. RESULTS: Euglycemic hyperinsulinemia reduced platelet reactivity, decreased fibrin clot density, and improved fibrinolytic efficiency in both groups. Platelet reactivity and aggregation increased during acute hypoglycemia in both groups, resolving at recovery. In type 2 diabetes, clot lysis times and clot maximum absorbance increased up to day 7 (P = 0.002 and 0.001 vs. euglycemia, respectively), but clots from control subjects without diabetes showed limited changes. Fibrin network density increased Δ 1.15 ± 0.28 fibers/μm2 at day 7 after the hypoglycemic clamp (P < 0.01 for glycemic arm), whereas fibrinogen and complement C3 increased after hypoglycemia up to day 7 in type 2 diabetes only. CONCLUSIONS: Antecedent hypoglycemia has acute and persistent prothrombotic effects, lasting at least 7 days, that were enhanced in individuals with type 2 diabetes. These findings identify mechanisms by which hypoglycemia might increase short- and medium-term risk of CV mortality.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Chow E, Iqbal A, Walkinshaw E, et al. Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes. Diabetes Care. 2018. PMID: 30327358. doi:10.2337/dc18-0050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。